Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis
about
Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness.Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art.BUDGET IMPACT ANALYSIS OF BELIMUMAB IN TREATING SYSTEMIC LUPUS ERYTHEMATOSUS.Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.
P2860
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Assessment of the Economic Imp ...... A Cost-Effectiveness Analysis
@ast
Assessment of the Economic Imp ...... A Cost-Effectiveness Analysis
@en
type
label
Assessment of the Economic Imp ...... A Cost-Effectiveness Analysis
@ast
Assessment of the Economic Imp ...... A Cost-Effectiveness Analysis
@en
prefLabel
Assessment of the Economic Imp ...... A Cost-Effectiveness Analysis
@ast
Assessment of the Economic Imp ...... A Cost-Effectiveness Analysis
@en
P2093
P2860
P1433
P1476
Assessment of the Economic Imp ...... A Cost-Effectiveness Analysis
@en
P2093
Francesca Pierotti
Giuseppe Turchetti
Ilaria Palla
Lara Pippo
Maarten Treur
P2860
P304
P356
10.1371/JOURNAL.PONE.0140843
P407
P577
2015-10-21T00:00:00Z